NeuroPace Inc (NASDAQ:NPCE)
| Market Cap | $273.89M-44.6% |
| Revenue (ttm) | $94.59M-0.3% |
| Net Income | -$18.92M+21.1% |
| EPS | -$0.56+26.1% |
| Shares Out | 34.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 749,375 |
| Open | $8.14 |
| Previous Close | $8.14 |
| Day's Range | $7.84 - $8.28 |
| 52-Week Range | $5.46 - $19.60 |
| Beta | 1.93 |
| Analysts | Buy |
| Price Target | $15.67(+97.11%) |
| Earnings Date | Mar 2, 2027 |
About NPCE
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
NeuroPace Inc Stock Analysis — InsiderScore
NeuroPace Inc scored higher than 92% of companies evaluated by InsiderBuying, and ranked 2nd out of 52 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at NeuroPace Inc bought $302.1K of stock across 3 purchases in the last 90 days, the largest of them $103.7K.
The average purchase added about 13% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Mar 2, 2027Earnings report
$NPCE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in NPCE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NPCE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NPCE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NPCE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NPCE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NPCE
| VTIVanguard Morningstar Total Stock Market ETF | $8.81M |
| IWMiShares Russell 2000 ETF | $5.65M |
| VXFVanguard Extended Market ETF | $3.71M |
| IWOiShares Russell 2000 Growth ETF | $1.97M |
| VTWOVanguard Russell 2000 ETF | $1.91M |
| IWCiShares Micro-Cap ETF | $655.24K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from NPCE’s recent data — informational, not investment advice
What’s Behind the Score
News check: Multiple analyst downgrades and price target cuts following Q3 earnings miss; concrete negative catalyst outweighs retention opinions.
Recent Insider Activity
Insider Score Trend Over Time
+3.0 since Nov 18Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| IBRN | iShares Neuroscience and Healthcare ETF | 0.51% |
| WDNA | WisdomTree BioRevolution Fund | 0.50% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 0.30% |
| OASC | OneAscent Enhanced Small and Mid Cap ETF | 0.13% |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 0.12% |
| IWC | iShares Micro-Cap ETF | 0.08% |
| FEAC | Fidelity Covington Trust - Fidelity Enhanced U.S. All-Cap Equity ETF | 0.04% |
Weight is the stock’s share of each fund’s holdings.
